The grades of six Pharmaceutical stocks are on the rise this week on . Each of these stocks is rated an “A” (“strong buy”) or “B” overall (“buy”).
Elan (NYSE:) ups its rating to a B (“buy”) this week after earning a C (“hold”) in the week before. Elan engages in research, development, and commercial activities primarily in the areas of Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis (MS). .
This week, Eli Lilly (NYSE:) is making solid headway. The company’s rating improves to an A (“strong buy”) from last week’s B (“buy”) rating. Eli Lilly discovers, develops, manufactures, and sells pharmaceutical products for humans and animals. .
Merck‘s (NYSE:) ratings are looking better this week, moving up to an A from last week’s B. Merck is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures. .
Pfizer
(NYSE:) is seeing ratings go up from a B last week to an A this week. Pfizer is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. .
Lannett Co.‘s (AMEX:) gets a higher grade this week, advancing from a C last week to a B. Lannett manufactures and distributes pharmaceutical products under its own trade name and under generic names. Shares of LCI have increased 15.2% over the past month, more than the 2% rise the S&P 500 experienced over the same time. .
Acura Pharmaceuticals (NASDAQ:) shows solid improvement this week. The company’s rating rises from a C to a B. Acura Pharmaceuticals engages in the research, development, and manufacture of pharmaceutical product candidates utilizing its proprietary Aversion and Impede technologies. .
¶¶Ņõ×īŠĀ°ę’s proprietary stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool .
